ALS is a rare, debilitating neurodegenerative disease that can affect anyone. We’ll meet a man who has been diagnosed with ALS and faces daily challenges associated with the disease. We’ll also hear from Dr. Steven Perrin, CEO and Chief Scientific Officer at the ALS Therapy Development Institute in Cambridge, MA, who will explain the latest research in their dedicated efforts to seek a cure. It’s part of the Mystery Behind the Rare Disease series on the Balancing Act.
Visit: [ Ссылка ]
Like: [ Ссылка ]
Follow: [ Ссылка ]
#TheBalancingAct #BalancingAct
103750
ALS - Behind The Mystery- Rare Disease
Теги
the balancing actlifetime networktalk showmorning showALSamyotrophic lateral sclerosisLou Gehrig’s diseaseneurodegenerative diseaseneurodegenerationneuro muscular diseasemuscle atrophiaALS Therapy Development InstituteALSTDIMT Pharma AmericaMTPAMitsubishi Tanabe Pharma AmericaMitsubishi Tanabe Pharma CorporationMTPC
